Whitebox Advisors’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-184,000
Closed -$1.85M 635
2022
Q4
$1.85M Hold
184,000
0.05% 188
2022
Q3
$1.81M Hold
184,000
0.05% 199
2022
Q2
$1.8M Hold
184,000
0.06% 190
2022
Q1
$1.8M Sell
184,000
-14,400
-7% -$140K 0.04% 205
2021
Q4
$1.93M Hold
198,400
0.04% 196
2021
Q3
$1.92M Sell
198,400
-1,600
-0.8% -$15.5K 0.04% 169
2021
Q2
$1.95M Buy
+200,000
New +$1.96M 0.04% 145

Other funds holding AONC

Whitebox Advisors's AONC Position: Q1 2023 in Review

Whitebox Advisors sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 184,000 shares — an estimated $1.85M sold.

Whitebox Advisors first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $1.95M in Q2 2021. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Whitebox Advisors reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Whitebox Advisors sold 184,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.85M.
  • Whitebox Advisors first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Whitebox Advisors's American Oncology Network, Inc. Class A Common Stock position peaked at $1.95M in Q2 2021.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Whitebox Advisors's 13F filing for Q1 2023, filed 15 May 2023.